A Phase 1/2 trial of SRA141 for the treatment of colorectal cancer

Trial Profile

A Phase 1/2 trial of SRA141 for the treatment of colorectal cancer

Planning
Phase of Trial: Phase I/II

Latest Information Update: 06 Mar 2018

At a glance

  • Drugs SRA 141 (Primary)
  • Indications Colorectal cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 06 Mar 2018 New trial record
    • 27 Feb 2018 According to a Sierra Oncology media release, the company is planning to submit an Investigational New Drug (IND) in the second half of 2018 to initiate this trial.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top